4//SEC Filing
Hadas Nicole R. 4
Accession 0001562180-24-001995
CIK 0001517022other
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 6:03 PM ET
Size
5.2 KB
Accession
0001562180-24-001995
Insider Transaction Report
Form 4
Hadas Nicole R.
VP General Counsel & Secretary
Transactions
- Sale
Common Stock
2024-02-27$1.52/sh−7,411$11,265→ 669,233 total
Footnotes (2)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.
- [F2]This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2023.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001602396
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 6:03 PM ET
- Size
- 5.2 KB